We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Combating Cancer: Microbubbles Cut Off Blood Supply and Help Deliver Drugs

News   Jun 06, 2018 | Original story from the American Institute of Physics

 
Combating Cancer: Microbubbles Cut Off Blood Supply and Help Deliver Drugs

Embolization -- the use of various techniques to cut off the blood vessels that feed tissue growth -- has gained traction over the past decades to treat cancerous tumors, and one specific version is gas embolotherapy. During this process, the blood supply is cut off using acoustic droplet vaporization, which uses microscopic gas bubbles induced by exposure to ultrasonic waves. Researchers have discovered that these bubbles could also be used as potential drug delivery systems. Shown here is a gas embolotherapy scenario. After the droplets were injected intravenously with or without therapeutic agents (e.g., chemotherapeutics or genes) and subsequently transported to the tumor microcirculation by blood flow, bubble formation was induced by ADV on demand. Credit: Dui Qin/Xi'an Jiaotong University

 
 
 

RELATED ARTICLES

Emerging Strategies for Treating Opioid-use Disorder

News

Anti-opioid immunopharmacotherapies (e.g., conjugate vaccines) that sequester drug peripherally, preventing opioids from reaching targeted receptors in the brain, have recently emerged as promising therapeutics.

READ MORE

New Imaging Tools that Trace Key Breast Cancer Enzymes May Help Guide Therapies

News

A set of emerging diagnostic tools may help identify breast cancer patients who are most likely to benefit from therapies that target important enzymes fueling a range of subtypes, including BCRA-mutated and triple negative cancers.

READ MORE

Cancer Vaccine Progress: Potentially Rich Source of Tumor Specific Antigens Identified

News

The immunogenicity and efficacy of tumor specific antigen vaccination for select antigens has been validated in mouse models of cancer. The researchers believe that clinical trials for human cancer vaccines could start within the next 2-3 years.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE